Other examples are miR-101, which can bind to the 3′UTR of APP to reduce the level of APP in AD, and miR-15a, which is significantly dysregulated in sporadic AD patients [160], and is predicted to bind to and regulate BACE1 and APP. This evidence concerns the gene BACE1 and Alzheimer disease.